Federal Institute for Drugs and Medical Devices (BfArM), PharmacoepidemiologyBonn, Germany
Disclosure information not submitted.
Identification of patient groups at high risk of fluoroquinolone-associated potentially life-threatening adverse events in German routine care: a population-based cohort study
Monday, August 26, 20245:45 PM – 6:00 PM CEST